CM
Canadian Imperial Bank of Commerce
There isn't enough reported data to score CM yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
CM Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CM's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CM.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $69.03 | -41% |
| Fair | 11x | $80.72 | -30% |
| Expensive | 14x | $97.67 | -16% |
| Current | 16x | $116 | — |
Historical ranges are pointers, not guarantees.
CM's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CM in the historical PE scenario, which offers more potential upside but is not a forecast.
CM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CM, with profitability improving.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $7.09 | +27% |
| Q1 2026 | $6.74 | +25% |
| Q4 2025 | $6.03 | +18% |
| Q3 2025 | $5.82 | +20% |
| Q2 2025 | $5.59 | +21% |
| Q1 2025 | $5.41 | +18% |
| Q4 2024 | $5.12 | +41% |
| Q3 2024 | $4.87 | +42% |
CM has the stronger earnings trend. Trailing diluted EPS is up 27% for CM versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.7B | +117% |
| Q1 2026 | $5.9B | +15% |
| Q4 2025 | $5.3B | +14% |
| Q3 2025 | $5.1B | +9.8% |
| Q2 2025 | $4.9B | +14% |
| Q1 2025 | $5.1B | +17% |
| Q4 2024 | $4.7B | +13% |
| Q3 2024 | $4.6B | +13% |
CM has the stronger quarterly revenue trend. Revenue is up 117% for CM versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 21% | -16 points |
| Q1 2026 | 42% | +2.8 points |
| Q4 2025 | 37% | +0.5 points |
| Q3 2025 | 37% | +0.5 points |
| Q2 2025 | 37% | +2.1 points |
| Q1 2025 | 39% | +4 points |
| Q4 2024 | 36% | +4.5 points |
| Q3 2024 | 37% | +6 points |
CM's operating margin was 21% last quarter, down 16 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
CM Free Cash Flow
CM and JPM do not have enough comparable growth data to identify a winner.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -14M shares |
| 1 year | -2.7% | -25.3M shares |
| 3 years | +0.5% | +4.2M shares |
| 5 years | +2.1% | +18.7M shares |
| Available history | +2.9% | +25.6M shares |
CM has 917M diluted shares, down 2.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $625.7M |
| Q4 2025 | $527.3M |
| Q3 2025 | $210.9M |
| Q2 2025 | — |
| Q1 2025 | $210.9M |
| Q4 2024 | — |
| Q3 2024 | $457M |
| Q2 2024 | $228.5M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CM Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 49.6 | Neutral |
CM's weekly RSI is 56 (neutral) and its Stochastic is 50 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CM PE vs Financial Services Sector
| Metric | CM | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 26% above |
| PE % | 98 | 63 | 35 pts above |
CM is trading at 16x earnings, a 26% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CM on valuation relative to its sector.
CM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.5 | 2.2% above |
| 20 week MA | $115.9 | 0.2% above |
| 50 week MA | $106.9 | 8.5% above |
| 100 week MA | $88.3 | 31% above |
| 200 week MA | $67.9 | 71% above |
CM has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.4 | $43.7 | +5.5% |
| 2021 | $43.7 | $58.0 | +33% |
| 2022 | $58.0 | $41.0 | -29% |
| 2023 | $41.0 | $48.1 | +17% |
| 2024 | $48.1 | $62.9 | +31% |
| 2025 | $62.9 | $93.0 | +48% |
| 2026 YTD | $93.0 | $116.0 | +25% |
CM has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.